Vulnerability in Quanovate Tech Inc. (Operating As Mira / Care) Android App

CVE-2026-67558

The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.4 (High). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N.

EPSS exploit prediction

EPSS: 0.003 (16.8th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 17th percentile — 16.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-67558: held from 0.002 to 0.003.

EPSS over last 30 days · oldest: 0.002 · newest: 0.003 · change: +0.001

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-67558?
CVE-2026-67558 is a high-severity vulnerability in Quanovate Tech Inc. (Operating As Mira / Care) Android App, classified under Authentication Bypass by Spoofing. CVSS score: 7.4/10. Published 2026-08-11.
How severe is CVE-2026-67558?
High severity. CVSS v3 base score is 7.4 out of 10.